Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract LB282: Overcoming chemotherapy resistance in pancreatic cancer: The impact of novel RAS inhibitors and tumor microenvironment modulation

Kevin C. Gulay, Jay Patel, Rithika Medari, Alexei Martsinkovskiy, Timothy Pham, Tatiana Hurtado De Mendoza, Andrew M. Lowy, Hervé Tiriac

Cancer Res (2025) 85 (8_Supplement_2): LB282.

https://doi.org/10.1158/1538-7445.AM2025-LB282

Published: 25 April 2025

View articletitled, Abstract LB282: Overcoming chemotherapy resistance in pancreatic cancer: The impact of novel RAS inhibitors and tumor microenvironment modulation

Journal Articles

Abstract 2582: Silencing MICAL2 expression in pancreatic cancer cells rewires the tumor microenvironment through the IL1-a/p38 MAP kinase/STAT-3 axis and sensitizes tumors to immune checkpoint blockade therapy

Bharti Garg, Evangeline S. Mose, Edgar Esparaze, Jay Patel, Rithika Medari, Sarah Sass, Alexei Martsinkovskiy, Asmina Courelli, Gisselle Gonzalez, Adam Engler, Parag Katira, Herve Tiriac, Andrew Lowy

Cancer Res (2025) 85 (8_Supplement_1): 2582.

https://doi.org/10.1158/1538-7445.AM2025-2582

Published: 21 April 2025

View articletitled, Abstract 2582: Silencing MICAL2 expression in pancreatic cancer cells rewires the tumor microenvironment through the IL1-a/p38 MAP kinase/STAT-3 axis and sensitizes tumors to immune checkpoint blockade therapy

Journal Articles

MICAL2 Promotes Pancreatic Cancer Growth and Metastasis

Cancer Res (2025) 85 (6): 1049–1063.

https://doi.org/10.1158/0008-5472.CAN-24-0744

Published: 14 March 2025

View articletitled, MICAL2 Promotes Pancreatic Cancer Growth and Metastasis

Includes: Supplementary data

Journal Articles

Abstract A052: Silencing MICAL2 Expression in Pancreatic Cancer Cells rewires the tumor microenvironment through the IL1-a/p38 MAP kinase/STAT-3 axis and Sensitizes Tumors to Immune Checkpoint Blockade therapy

Bharti Garg, Evangeline Mose, Edgar Esparaza, Jay Patel, Rithika Medari, Alexei Martsinkovskiy, Carrie Bishop, Gissele Gonzalez, Adam Engler, Parag Katira, Herve Tiriac, Andrew M Lowy

Cancer Res (2024) 84 (17_Supplement_2): A052.

https://doi.org/10.1158/1538-7445.PANCREATIC24-A052

Published: 15 September 2024

View articletitled, Abstract A052: Silencing MICAL2 Expression in Pancreatic Cancer Cells rewires the tumor microenvironment through the IL1-a/p38 MAP kinase/STAT-3 axis and Sensitizes Tumors to Immune Checkpoint Blockade therapy

Journal Articles

Abstract B055: Harnessing cytomegalovirus immunity against pancreatic tumors for immunotherapy

Remi Marrocco, Jay Patel, Rithika Medari, Siming Sun, Kevin Gulay, Alexei Martsinkovskiy, Simon Brunel, Eduardo Lucero-Meza, Evangeline Mose, Andrew Lowy, Chris Benedict, Tatiana Hurtado de Mendoza

Cancer Res (2024) 84 (17_Supplement_2): B055.

https://doi.org/10.1158/1538-7445.PANCREATIC24-B055

Published: 15 September 2024

View articletitled, Abstract B055: Harnessing cytomegalovirus immunity against pancreatic tumors for immunotherapy

Journal Articles

Abstract 2470: Harnessing cytomegalovirus immunity against pancreatic tumors for immunotherapy

Remi Marrocco, Jay Patel, Siming Sun, Rithika Medari, Kevin Gulay, Eduardo Lucero-Meza, Evangeline Mose, Andrew Lowy, Chris Benedict, Tatiana Hurtado de Mendoza

Cancer Res (2024) 84 (6_Supplement): 2470.

https://doi.org/10.1158/1538-7445.AM2024-2470

Published: 22 March 2024

View articletitled, Abstract 2470: Harnessing cytomegalovirus immunity against pancreatic tumors for immunotherapy

Journal Articles

Abstract 6777: An ex-vivo organotypic culture platform of mucinous carcinomatosis peritonei identifies CDK4-6 inhibition as a novel treatment

Jonathan Weitz, Daisuke Nishizaki, Jay Patel, Isabella Ng, Siming Sun, Dana Ramms, Jingjing Zou, Joel Baumgartner, Kaitlyn Kelly, Hitendra Patel, Rebekah White, Jula Veerapong, Peter Vu, Silvio Gutkind, Herve Tiriac, Shumei Kato, Andrew Lowy

Cancer Res (2024) 84 (6_Supplement): 6777.

https://doi.org/10.1158/1538-7445.AM2024-6777

Published: 22 March 2024

View articletitled, Abstract 6777: An ex-vivo organotypic culture platform of mucinous carcinomatosis peritonei identifies CDK4-6 inhibition as a novel treatment

Journal Articles

Abstract B096: Acquired resistance to KRAS inhibition modulates the pancreatic cancer tumor microenvironment

Kevin Christian Montecillo Gulay, Jay Patel, Isabella Ng, Tatiana Hurtado de Mendoza, Herve Tiriac, Andrew Lowy

Cancer Res (2024) 84 (2_Supplement): B096.

https://doi.org/10.1158/1538-7445.PANCA2023-B096

Published: 16 January 2024

View articletitled, Abstract B096: Acquired resistance to KRAS inhibition modulates the pancreatic cancer tumor microenvironment

Journal Articles

Abstract A039: Silencing MICAL2 expression in pancreatic cancer cells reduces IL-1A expression and inhibits tumor growth through a CD8+ T cell dependent mechanism

Bharti Garg, EvanGeline Mose, Edgar Esparza, Jay Patel, Sarah Sass, Alexei Martsinkovskiy, Dawn Jacquish, Herve Tiriac, Andrew M. Lowy

Cancer Res (2024) 84 (2_Supplement): A039.

https://doi.org/10.1158/1538-7445.PANCA2023-A039

Published: 16 January 2024

View articletitled, Abstract A039: Silencing MICAL2 expression in pancreatic cancer cells reduces IL-1A expression and inhibits tumor growth through a CD8+ T cell dependent mechanism

Journal Articles

Dual Inhibition of KRAS^G12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma

Kevin Christian Montecillo Gulay, Xinlian Zhang, Vasiliki Pantazopoulou, Jay Patel, Edgar Esparza, Deepa Sheik Pran Babu, Satoshi Ogawa, Jonathan Weitz, Isabella Ng, Evangeline S. Mose, Minya Pu, Dannielle D. Engle, Andrew M. Lowy, Hervé Tiriac

Cancer Res (2023) 83 (18): 3001–3012.

https://doi.org/10.1158/0008-5472.CAN-23-1313

Published: 15 September 2023

View articletitled, Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma

Includes: Supplementary data

Journal Articles

Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma

Deepak Rohila, In Hwan Park, Timothy V. Pham, Jonathan Weitz, Tatiana Hurtado de Mendoza, Suresh Madheswaran, Mehreen Ishfaq, Cooper Beaman, Elisabette Tapia, Siming Sun, Jay Patel, Pablo Tamayo, Andrew M. Lowy, Shweta Joshi

Cancer Res (2023) 83 (16): 2675–2689.

https://doi.org/10.1158/0008-5472.CAN-22-3645

Published: 15 August 2023

View articletitled, Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma

Includes: Supplementary data

Journal Articles

Abstract C021: Targeted delivery of neoantigens to pancreatic cancer to enable immunotherapy

Siming Sun, Jay Patel, Alexis Wascher, Evangeline S. Mose, Dawn Jaquish, Spencer Brightman, Stephen Schoenberger, Andrew M. Lowy, Tatiana Hurtado de Mendoza

Cancer Res (2022) 82 (22_Supplement): C021.

https://doi.org/10.1158/1538-7445.PANCA22-C021

Published: 15 November 2022

View articletitled, Abstract C021: Targeted delivery of neoantigens to pancreatic cancer to enable immunotherapy

Journal Articles

Abstract 385: iRGD mediated delivery of neoantigens to enable immunotherapy in integrin b5-rich tumors

Tatiana Hurtado de Mendoza, Evangeline S. Mose, Gregory P. Botta, Gary B. Braun, Venkata R. Kotamraju, Randall P. French, Kodai Suzuki, Norio Miyamura, Siming Sun, Jay Patel, Tambet Teesalu, Erkki Ruoslahti, Kazuki N. Sugahara, Andrew M. Lowy

Cancer Res (2022) 82 (12_Supplement): 385.

https://doi.org/10.1158/1538-7445.AM2022-385

Published: 15 June 2022

View articletitled, Abstract 385: iRGD mediated delivery of neoantigens to enable immunotherapy in integrin b5-rich tumors

Journal Articles

Abstract 666: Determination of biomarkers for neuronal damage in bortezomib (BTZ) induced peripheral neuropathy (BIPN)

Paramjot Kaur, Theodore L. Mathuram, Vineela Nagamalla, Jay Patel, Thiagarajan Venkatesan, Alicia Fernandez-Fernandez, M. Samuel Cheng, Appu Rathinavelu

Cancer Res (2019) 79 (13_Supplement): 666.

https://doi.org/10.1158/1538-7445.AM2019-666

Published: 01 July 2019

View articletitled, Abstract 666: Determination of biomarkers for neuronal damage in bortezomib (BTZ) induced peripheral neuropathy (BIPN)

Journal Articles

Abstract LB-073: Epigenome evolution in relapsed acute myeloid leukemia

Cancer Res (2016) 76 (14_Supplement): LB-073.

https://doi.org/10.1158/1538-7445.AM2016-LB-073

Published: 15 July 2016

View articletitled, Abstract LB-073: Epigenome evolution in relapsed acute myeloid leukemia

Journal Articles

Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias

Omar Abdel-Wahab, Taghi Manshouri, Jay Patel, Kelly Harris, JinJuan Yao, Cyrus Hedvat, Adriana Heguy, Carlos Bueso-Ramos, Hagop Kantarjian, Ross L. Levine, Srdan Verstovsek

Cancer Res (2010) 70 (2): 447–452.

https://doi.org/10.1158/0008-5472.CAN-09-3783

Published: 13 January 2010

View articletitled, Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias

Includes: Supplementary data

Journal Articles

Celecoxib, a Selective Cyclooxygenase 2 Inhibitor, Protects against Human Epidermal Growth Factor Receptor 2 (HER-2)/neu-induced Breast Cancer

Louise R. Howe, Kotha Subbaramaiah, Jay Patel, Jaime L. Masferrer, Aparna Deora, Clifford Hudis, Howard T. Thaler, William J. Muller, Baoheng Du, Anthony M. C. Brown, Andrew J. Dannenberg

Cancer Res (2002) 62 (19): 5405–5407.

Published: 01 October 2002

View articletitled, Celecoxib, a Selective Cyclooxygenase 2 Inhibitor, Protects against Human Epidermal Growth Factor Receptor 2 (HER-2)/neu-induced Breast Cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract LB282: Overcoming chemotherapy resistance in pancreatic cancer: The impact of novel RAS inhibitors and tumor microenvironment modulation

Abstract 2582: Silencing MICAL2 expression in pancreatic cancer cells rewires the tumor microenvironment through the IL1-a/p38 MAP kinase/STAT-3 axis and sensitizes tumors to immune checkpoint blockade therapy

MICAL2 Promotes Pancreatic Cancer Growth and Metastasis

Abstract A052: Silencing MICAL2 Expression in Pancreatic Cancer Cells rewires the tumor microenvironment through the IL1-a/p38 MAP kinase/STAT-3 axis and Sensitizes Tumors to Immune Checkpoint Blockade therapy

Abstract B055: Harnessing cytomegalovirus immunity against pancreatic tumors for immunotherapy

Abstract 2470: Harnessing cytomegalovirus immunity against pancreatic tumors for immunotherapy

Abstract 6777: An ex-vivo organotypic culture platform of mucinous carcinomatosis peritonei identifies CDK4-6 inhibition as a novel treatment

Abstract B096: Acquired resistance to KRAS inhibition modulates the pancreatic cancer tumor microenvironment

Abstract A039: Silencing MICAL2 expression in pancreatic cancer cells reduces IL-1A expression and inhibits tumor growth through a CD8+ T cell dependent mechanism

Dual Inhibition of KRAS^G12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma

Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma

Abstract C021: Targeted delivery of neoantigens to pancreatic cancer to enable immunotherapy

Abstract 385: iRGD mediated delivery of neoantigens to enable immunotherapy in integrin b5-rich tumors

Abstract 666: Determination of biomarkers for neuronal damage in bortezomib (BTZ) induced peripheral neuropathy (BIPN)

Abstract LB-073: Epigenome evolution in relapsed acute myeloid leukemia

Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias

Celecoxib, a Selective Cyclooxygenase 2 Inhibitor, Protects against Human Epidermal Growth Factor Receptor 2 (HER-2)/neu-induced Breast Cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only